Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4Q0A

Vitamin D Receptor complex with lithocholic acid

Summary for 4Q0A
Entry DOI10.2210/pdb4q0a/pdb
Related2HC4 2HCD
DescriptorVitamin D3 receptor A, Nuclear receptor coactivator 2, (3beta,5beta,14beta,17alpha)-3-hydroxycholan-24-oic acid, ... (4 entities in total)
Functional Keywordsalpha-helical sandwich, transcription factor, calcitriol binding, dna binding, nucleus, gene regulation
Biological sourceDanio rerio (leopard danio,zebra danio,zebra fish)
More
Cellular locationNucleus: Q9PTN2 Q15596
Total number of polymer chains2
Total formula weight36032.31
Authors
Belorusova, A.,Rochel, N. (deposition date: 2014-04-01, release date: 2014-07-02, Last modification date: 2024-02-28)
Primary citationBelorusova, A.Y.,Eberhardt, J.,Potier, N.,Stote, R.H.,Dejaegere, A.,Rochel, N.
Structural insights into the molecular mechanism of vitamin d receptor activation by lithocholic Acid involving a new mode of ligand recognition.
J.Med.Chem., 57:4710-4719, 2014
Cited by
PubMed Abstract: The vitamin D receptor (VDR), an endocrine nuclear receptor for 1α,25-dihydroxyvitamin D3, acts also as a bile acid sensor by binding lithocholic acid (LCA). The crystal structure of the zebrafish VDR ligand binding domain in complex with LCA and the SRC-2 coactivator peptide reveals the binding of two LCA molecules by VDR. One LCA binds to the canonical ligand-binding pocket, and the second one, which is not fully buried, is anchored to a site located on the VDR surface. Despite the low affinity of the alternative site, the binding of the second molecule promotes stabilization of the active receptor conformation. Biological activity assays, structural analysis, and molecular dynamics simulations indicate that the recognition of two ligand molecules is crucial for VDR agonism by LCA. The unique binding mode of LCA provides clues for the development of new chemical compounds that target alternative binding sites for therapeutic applications.
PubMed: 24818857
DOI: 10.1021/jm5002524
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon